Discontinued — last reported Q3 '23

Investing

Acquisitions

Eli Lilly Acquisitions increased by 848.0% to $1.06B in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ3 2023

How to read this metric

High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.

Detailed definition

This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...

Peer comparison

Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.

Metric ID: acquisitions

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q3 '23Q4 '23Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$327.20M$0.00$1.04B$300.00K$0.00$0.00$549.40M$111.60M$1.06B
QoQ Change-100.0%-100.0%-100.0%-79.7%+848.0%
YoY Change+219.1%-100.0%>999%
Range$0.00$1.06B
Avg YoY Growth>999%
Median YoY Growth+219.1%

Frequently Asked Questions

What is Eli Lilly's acquisitions?
Eli Lilly (LLY) reported acquisitions of $1.06B in Q1 2026.
What does acquisitions mean?
Cash spent to buy other companies or business units.